We are live on ! Find out more
MLICM

Metropolitan Life Insurance Company (MetLife) Portfolio holdings

AUM $328M
1-Year Est. Return 9.77%
This Fund
S&P 500
This Quarter Est. Return
+8.95%
1 Year Est. Return
+9.77%
3 Year Est. Return
+50.33%
5 Year Est. Return
+74.21%
10 Year Est. Return
+345.05%
AUM
$2.06B
AUM Growth
+$107M
Cap. Flow
-$28.6M
Cap. Flow %
-1.39%
Top 10 Hldgs %
29.47%
Holding
2,720
New
413
Increased
568
Reduced
616
Closed
259

Sector Composition

Rank Sector Weight
1 Technology 24.3%
2 Healthcare 11.82%
3 Financials 10.45%
4 Consumer Discretionary 9.39%
5 Industrials 7.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CVCO icon
851
Cavco Industries
CVCO
$4.67B
$139K 0.01%
471
RLJ icon
852
RLJ Lodging Trust
RLJ
$1.67B
$139K 0.01%
13,529
-135
-1% -$1.4K
BOOT icon
853
Boot Barn
BOOT
$4.92B
$139K 0.01%
1,639
PRGS icon
854
Progress Software
PRGS
$1.83B
$138K 0.01%
2,379
+59
+3% +$3.35K
STAA icon
855
STAAR Surgical
STAA
$1.26B
$138K 0.01%
2,629
+68
+3% +$4.14K
CBZ icon
856
CBIZ
CBZ
$2.96B
$138K 0.01%
2,591
+63
+2% +$3.24K
ALRM icon
857
Alarm.com
ALRM
$2.74B
$138K 0.01%
2,670
WD icon
858
Walker & Dunlop
WD
$1.47B
$138K 0.01%
1,741
+116
+7% +$8.38K
IVT icon
859
InvenTrust Properties
IVT
$2.62B
$138K 0.01%
5,947
-17
-0.3% -$384
KRYS icon
860
Krystal Biotech
KRYS
$9.72B
$137K 0.01%
1,170
+43
+4% +$4.39K
ACIW icon
861
ACI Worldwide
ACIW
$5.42B
$137K 0.01%
5,928
-295
-5% -$7.13K
CBU icon
862
Community Bank
CBU
$3.46B
$137K 0.01%
2,929
+79
+3% +$3.87K
AXNX
863
DELISTED
Axonics, Inc. Common Stock
AXNX
$137K 0.01%
2,719
JXN icon
864
Jackson Financial
JXN
$9.1B
$137K 0.01%
4,468
+294
+7% +$9.47K
JBGS
865
JBG SMITH
JBGS
$692M
$137K 0.01%
9,085
+6,033
+198% +$87.9K
TCBI icon
866
Texas Capital Bancshares
TCBI
$4.38B
$137K 0.01%
2,653
+85
+3% +$4.24K
IOSP icon
867
Innospec
IOSP
$2.31B
$136K 0.01%
1,359
+45
+3% +$4.51K
VIAV icon
868
Viavi Solutions
VIAV
$10.6B
$136K 0.01%
12,038
CVNA icon
869
Carvana
CVNA
$81B
$136K 0.01%
+26,230
New +$72.7K
STNG icon
870
Scorpio Tankers
STNG
$3.93B
$136K 0.01%
+2,879
New +$142K
SAGE
871
DELISTED
Sage Therapeutics
SAGE
$136K 0.01%
2,891
GNW icon
872
Genworth Financial
GNW
$3.77B
$136K 0.01%
27,148
+1,979
+8% +$10.8K
ENVX icon
873
Enovix
ENVX
$966M
$136K 0.01%
8,597
+1,740
+25% +$20.2K
ASB icon
874
Associated Banc-Corp
ASB
$6.07B
$134K 0.01%
8,279
SHOO icon
875
Steven Madden
SHOO
$3.46B
$133K 0.01%
4,081
-193
-5% -$6.44K

Similar funds

Metropolitan Life Insurance Company (MetLife)'s Q2 2023 Portfolio in Review

As of Q2 2023, Metropolitan Life Insurance Company (MetLife) held 2,720 positions worth $2.06B, up 5.5% from $1.95B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Metropolitan Life Insurance Company (MetLife)'s Q2 2023 filing shows 413 new, 568 increased, 616 reduced and 259 closed positions. Its largest new stake was Alphabet (Google) Class C: 222,708 shares worth $26.9M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $16.1M.

By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 22% a quarter earlier, followed by Healthcare and Financials.

  • Metropolitan Life Insurance Company (MetLife)'s largest Q2 2023 buy was Alphabet (Google) Class C: 222,708 shares worth $26.9M.
  • Metropolitan Life Insurance Company (MetLife) added most to Vanguard Total Bond Market in Q2 2023, an estimated $15M increase.
  • Metropolitan Life Insurance Company (MetLife)'s biggest Q2 2023 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $16.1M.
  • Metropolitan Life Insurance Company (MetLife) fully exited Iridium Communications in Q2 2023, selling an estimated $418K.
  • Metropolitan Life Insurance Company (MetLife)'s ten largest holdings make up 29% of its $2.06B portfolio in Q2 2023.
  • Metropolitan Life Insurance Company (MetLife) opened 413 new positions and closed 259 in Q2 2023.
  • Metropolitan Life Insurance Company (MetLife)'s portfolio value rose 5.5% quarter-over-quarter to $2.06B.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2023, filed 10 Aug 2023.